A Phase 1, Open-label, Sequential Crossover Study to Evaluate the Effect of Hemodialysis on the Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease
Latest Information Update: 12 May 2014
At a glance
- Drugs Enarodustat (Primary)
- Indications Renal failure
- Focus Pharmacokinetics
- Sponsors Akros Pharma
- 17 Mar 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Nov 2013 New trial record